Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness Perceptions.
actinic keratosis
awareness
illness perception
non-melanoma skin cancer
prevention
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
21 07 2022
21 07 2022
Historique:
received:
22
06
2022
revised:
13
07
2022
accepted:
19
07
2022
entrez:
25
7
2022
pubmed:
26
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Decreased illness perception among actinic keratoses (AK) patients is a major barrier to the effective management of AK. We aimed to investigate patients' illness and treatment perceptions, their correlation to demographics and AK/skin cancer history, and secondarily the influence of these perspectives on treatment and sunscreen use. Participants completed questionnaires based on the Brief Illness Perception Questionnaire and statistical analysis was performed. In total, 208 AK patients were enrolled. A large proportion were poorly aware of the disease (41.4%), with less than half (43%) being familiar with AK. Patients were aware of the chronic nature of the disease and its correlation to sunlight regardless of demographic characteristics. The level of education played a role in disease awareness ( Improved awareness of AK is necessary to increase treatment seeking and compliance, regarding both treatment and sunscreen use. Dermatologists' statements may have critical influence on patients' decisions to receive treatment for AK.
Sections du résumé
BACKGROUND
Decreased illness perception among actinic keratoses (AK) patients is a major barrier to the effective management of AK.
OBJECTIVE
We aimed to investigate patients' illness and treatment perceptions, their correlation to demographics and AK/skin cancer history, and secondarily the influence of these perspectives on treatment and sunscreen use.
MATERIALS AND METHODS
Participants completed questionnaires based on the Brief Illness Perception Questionnaire and statistical analysis was performed.
RESULTS
In total, 208 AK patients were enrolled. A large proportion were poorly aware of the disease (41.4%), with less than half (43%) being familiar with AK. Patients were aware of the chronic nature of the disease and its correlation to sunlight regardless of demographic characteristics. The level of education played a role in disease awareness (
CONCLUSION
Improved awareness of AK is necessary to increase treatment seeking and compliance, regarding both treatment and sunscreen use. Dermatologists' statements may have critical influence on patients' decisions to receive treatment for AK.
Identifiants
pubmed: 35877268
pii: curroncol29070408
doi: 10.3390/curroncol29070408
pmc: PMC9323725
doi:
Substances chimiques
Sunscreening Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5150-5163Références
Pharmacoeconomics. 2009;27(6):451-64
pubmed: 19640009
Dermatol Ther. 2021 Mar;34(2):e14833
pubmed: 33527673
J Dermatolog Treat. 2017 Aug;28(5):431-442
pubmed: 27796187
J Cosmet Laser Ther. 2008 Jun;10(2):81-6
pubmed: 18569260
Cancer. 2001 Sep 1;92(5):1315-24
pubmed: 11571748
An Bras Dermatol. 2012 May-Jun;87(3):425-34
pubmed: 22714759
Clin Cosmet Investig Dermatol. 2017 May 17;10:179-184
pubmed: 28553130
JAMA Dermatol. 2017 May 1;153(5):421-426
pubmed: 28114674
Br J Dermatol. 2017 Jan;176(1):20-43
pubmed: 28098380
Int J Dermatol. 2004 Sep;43(9):687-92
pubmed: 15357755
Psychol Health. 2015;30(11):1361-85
pubmed: 26181764
J Health Psychol. 2015 Jul;20(7):942-53
pubmed: 24140616
Cancer Epidemiol. 2013 Apr;37(2):127-32
pubmed: 23295002
J Dermatolog Treat. 2020 Sep;31(6):576-582
pubmed: 31625770
Health Qual Life Outcomes. 2015 Jul 29;13:111
pubmed: 26220553
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2199-210
pubmed: 20643826
J Family Med Prim Care. 2020 Jan 28;9(1):374-378
pubmed: 32110621
J Dermatolog Treat. 2007;18(1):53-8
pubmed: 17365267
J Am Acad Dermatol. 2007 Mar;56(3):426-31
pubmed: 17184877
Br J Dermatol. 2015 Jan;172(1):130-7
pubmed: 25039441
Curr Probl Dermatol. 2015;46:1-7
pubmed: 25561199
Ital J Dermatol Venerol. 2021 Dec;156(6):703-708
pubmed: 32938163
Expert Opin Emerg Drugs. 2020 Mar;25(1):49-58
pubmed: 32067498
Int J Environ Res Public Health. 2015 Nov 09;12(11):14260-74
pubmed: 26569274
J Gen Intern Med. 2007 Oct;22(10):1429-33
pubmed: 17674111
Health Psychol Open. 2019 Apr 23;6(1):2055102919844504
pubmed: 31041109
Br J Dermatol. 2016 May;174(5):1005-10
pubmed: 26650251
Pharmaceutics. 2022 Jan 27;14(2):
pubmed: 35214027
JMIR Mhealth Uhealth. 2019 Jul 02;7(7):e13844
pubmed: 31267978
J Eur Acad Dermatol Venereol. 2017 Mar;31 Suppl 2:17-20
pubmed: 28263022
J Photochem Photobiol B. 1992 Jul 30;14(4):275-92
pubmed: 1403373
Acad Med. 2000 Aug;75(8):840-2
pubmed: 10965864
An Bras Dermatol. 2019 Nov - Dec;94(6):637-657
pubmed: 31789244
J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S28-38
pubmed: 23228304
Curr Opin Psychiatry. 2007 Mar;20(2):163-7
pubmed: 17278916
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):552-5
pubmed: 15324391
J Clin Aesthet Dermatol. 2010 Jun;3(6):39-44
pubmed: 20725550
Int J Dermatol. 2005 Feb;44(2):107-11
pubmed: 15689206
Dermatol Ther (Heidelb). 2015 Mar;5(1):19-35
pubmed: 25647448
Photodermatol Photoimmunol Photomed. 2017 May;33(3):143-155
pubmed: 28130797
BMC Med Inform Decis Mak. 2014 Aug 26;14:76
pubmed: 25155972
Acta Derm Venereol. 2014 May;94(3):271-5
pubmed: 24002676
J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S2-9
pubmed: 23228302
Health Qual Life Outcomes. 2010 Sep 13;8:99
pubmed: 20836888
Pharmacotherapy. 1997 Jan-Feb;17(1):126-32
pubmed: 9017773
Patient Prefer Adherence. 2013 Dec 17;8:35-41
pubmed: 24379656